Literature DB >> 8619467

Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat.

C B Hughes1, H P Grewal, L W Gaber, M Kotb, A B El-din, L Mann, A O Gaber.   

Abstract

BACKGROUND: Elevated levels of tumor necrosis factor-alpha (TNFalpha) have been measured in a lethal model acute pancreatitis (AP) and may contribute to the pathophysiologic sequelae of the disease.
METHODS: To determine the significance of anti-TNFalpha therapy on survival and disease manifestations in a clinically relevant model of AP, a rat model was developed using a retrograde pancreatic ductal infusion of bile. Animals were randomized to no treatment (n = 30) or treatment with anti-TNFalpha antibody 15 minutes prior to induction of AP (n = 30). Five treated and 5 untreated rats were killed at various time periods up to 72 hours to provide temporal characterization of TNFalpha activity in AP.
RESULTS: A burst Of TNFalpha activity in the serum of untreated pancreatitis animals between 1 and 3 hours after induction of the disease is prevented by pretreatment with anti-TNFalpha antibody.
CONCLUSIONS: These findings provide a plausible mechanism for the improvement in biochemical and histologic parameters as well as in overall survival in an experimental model of acute pancreatitis in the rat.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619467     DOI: 10.1016/s0002-9610(97)89568-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  39 in total

1.  Immunological changes of mild acute pancreatitis in late-stage alcoholic chronic pancreatitis.

Authors:  C Hanck; S Rossol; M V Singer
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Current concept of pathogenesis of severe acute pancreatitis.

Authors:  Xie-Ning Wu
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis.

Authors:  En-Qiang Mao; Yao-Qing Tang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis.

Authors:  A S Gukovskaya; I Gukovsky; V Zaninovic; M Song; D Sandoval; S Gukovsky; S J Pandol
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis.

Authors:  Adam S Paszkowski; Bettina Rau; Jens M Mayer; Peter Möller; Hans G Beger
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 6.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

7.  Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial.

Authors:  Xinying Wang; Weiqin Li; Feng Zhang; Liya Pan; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

Review 8.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis.

Authors:  Tamas Letoha; Csaba Somlai; Tamas Takacs; Annamaria Szabolcs; Katalin Jarmay; Zoltan Rakonczay; Peter Hegyi; Ilona Varga; Jozsef Kaszaki; Istvan Krizbai; Imre Boros; Erno Duda; Erzsebet Kusz; Botond Penke
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

10.  Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency.

Authors:  Ye Chen; Mark M W Chong; Rima Darwiche; Helen E Thomas; Thomas W H Kay
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.